Quantity of Salivary Immunoglobulin A, Lysozyme and Magnesium in Patients with Burning Mouth Syndrome and Xerostomia by Vanja Vučićević-Boras et al.
A S CActa Stomatol Croat, Vol. 35, br. 2, 2001. 211
Quantity of Salivary
Immunoglobulin A, Lysozyme
and Magnesium in Patients with
Burning Mouth Syndrome and
Xerostomia
Summary
Recent studies suggest a connection between burning mouth syn-
drome (BMS) and the quantitiy and quality of saliva. The aim of our
study was to determine quantities of salivary immunoglobulin A (sIgA),
lysozyme and magnesium in unstimulated and stimulated saliva of
patients with burning mouth syndrome and xerostomia. Salivary sam-
ples were obtained by sialometry. Salivary immunoglobulin A was
determined by radial immunodiffusion according to Manzini, lysozyme
levels were obtained according to Osserman and Lowlor, and magne-
sium was determined using atomic absorbance spectrophotometry.
Levels of sIgA were decreased in stimulated whole saliva of patients
with BMS and xerostomia when compared to those in unstimulated
saliva (p<0.001). Lysozyme levels were also lower in stimulated whole
saliva in such patients when compared to the levels in unstimulated
saliva (p<0.001). Magnesium levels remain unchanged with regard to
the salivary stimulation. The results of our study indicate that the
quantity and quality of saliva could have an impact on symptoms of
burning mouth syndrome.





1Department of Oral Medicine







Received: September 15, 2000
Address for correspondence:
Vanja VuËiÊeviÊ-Boras
Department of Oral Medicine
School of Dental Medicine






Burning mouth syndrome is an intraoral pain
disorder characterized by burning sensations of the
oral mucosa with healthy appearance of the oral
mucosa. Epidemiology varies in different countries,
from 1.5% in England  to 2.6% in the United States.
However, prevalence is highest in menopausal women,
being 10-40% (1,2,3). Symptoms are usually a burn-
ing sensation, sometimes even pain, taste distur-
bances and dry mouth (4). Most usually affected
sites are the tongue, lips, and palate (1,3,5). Eti-
ological factors can be divided into local, systemic
and psychological. Factors contributing in the eti-
opathogenesis of BMS are candidiasis, galvanism,
xerostomia, prosthetic appliances, contact allergy
and parafunctional habits and mandibular dysfunc-
tion, hematological deficiences of iron, calcium,
zinc, vitamin B1, B2, B6, B12 and folic acid (6-17).
More recently numerous studies have reported a
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connection between the quantity and quality of
saliva in patients suffering from burning mouth
syndrome. Data based upon correlation between
BMS and xerostomia in literature are controversial,
although most of the studies suggest a positive
relationship between these two disorders. 
Mott, Grushka, Sessle (3) report that although
changes in saliva composition and their connection
to BMS are only to be speculated upon, it could be
of great significance to confirm that connection. The
same authors report that the majority of studies have
failed to demonstrate significant changes in the
quantitiy and quality of saliva in patients with BMS,
and also that some studies have reported changes in
the protein quantity, immunoglobulins, phosphates
and pH value in patients with BMS (19, 20). 
Glass (7) suggests that xerostomia is a local
contributing factor in the development of BMS, and
other authors also found a higher or lower per-
centage prevalence of xerostomia in burning mouth
syndrome patients (8, 9). 
Controversial data exist in regard to protein
composition in the saliva of patients with burning
mouth syndrome (18,19,20,21). 
Salivary IgA acts as a protective agent in the oral
cavity, which has been investigated by numerous
authors (22,23,24,25) in various couintries, also in
unstimulated and stimulated saliva (26-31).
Salivary lysozyme has been investigated both in
healthy (24,32,33,34) and diseased individuals (23,
35,36,37,38) with regard to its antimicrobial activ-
ity.
To date investigations on salivary magnesium
quantity (25,31,39) show completely different val-
ues in healthy persons.
Materials and Methods
The aim of this study was to evaluate a cor-
relation between burning mouth syndrome and
xerostomia, and also levels of salivary IgA, lyso-
zyme and magnesium in unstimulated and stim-
ulated saliva of these patients.
Forty-three patients with burning mouth syn-
drome and xerostomia were examined from the
Department of Oral Medicine, School of Dental
Medicine in Zagreb, during 1998. There were 41
women and 2 men, average age 69.2 yrs. Quan-
tification of saliva was determined by two meas-
urements, using sialometry between 8-12 a.m. The
unstimulated saliva was obtained by expectoration
method in calibrated tubes (0.1 ml scale) during five
minutes while participants were sitting. The stim-
ulated saliva samples were obtained after chewing
gum for one minute in dentate individuals or after
drinking 1% C-vitamin solution followed by expec-
toration into calibrated tubes for five minutes. C-
-vitamin solution was made by dissolving 1g of
ascorbic acid in 1 dcl of water. The results were
expressed per one minute and levels below 0.2 ml
per minute were considered xerostomic. Saliva sam-
ples were centrifuged at 800 rotations for ten min-
utes and stored at -20°C until analysis. The salivary
analysis was performed in laboratories at the Clinical
Hospital Centre Rebro.
Salivary immunoglobulin A was determined
using radial immunodiffusion according to Manzini
(40) on standardized kits (LC Partigen IgA, Behring
Diagnostics, Marburg, Germany). LC partigen con-
sists of plates for immunodiffusion which contain an
agarose gel layer with nonspecific antisera on rel-
evant human plasma protein. Antibodies are obtained
from immunized rabbit.
Lysozyme was determined according to Osser-
man and Lowlor (41). The method is based on the
ability of enzyme to lyse Micrococcus lysodeicticus.
The sample was placed onto agarose plates con-
taining microorganism and lyse zones determined
by the concentration of enzyme in the sample.
Human urinary lysozyme serves as a standard. 
Magnesium levels were determined by atomic
absorbance spectrophotometry (42). Satatistical
analysis was performed using Student t test and
Wilcoxon test.
Results
Average values of salivary immunoglobulin A in
unstimulated whole saliva of our patients were
approximately the same (X=0.37 g/L; M=0.35 g/L;
Mod=0.20 g/L) with a large dispersion in borders
±1SD (SD=0.20 g/L) and span (0-1,10 g/L) and we
concluded that distribution was normal. Average
values of salivary immunoglobulin A stimulated
whole saliva of our patients were approximately the
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same (X=0.18 g/L; M=0. 147 g/L; Mod=0.26 g/L)
with a large dispersion in borders ±1SD (SD=
=0.15g/L) and span (0-0.83 g/L) and we concluded
that the appearance of distribution was normal
(Figure 1).
Average values of lysozyme in unstimulated
whole saliva of our patients were approximately the
same (X=35.22 mg/L; M=35 mg/L; Mod= 35 mg/L)
with a large dispersion in borders  ±1SD (SD=20.74
mg/L) and span (5-75.0 mg/L) and we concluded
that distribution was normal. Average values of
lysozyme in stimulated whole saliva of our patients
were approximately the same (X=29.01 mg/L; M=
=25 mg/L; Mod= 5 mg/L) with a large dispersion
in borders ±1SD (SD=20.74 mg /L) and span (5-
-75.0 mg/L) and we concluded that distribution was
normal. Average values of magnesium in stimulated
whole saliva of our patients were aproximately the
same (X= 29.01 mgl/L; M=25 mg/L; Mod= 5 mg/L)
with a large dispersion in borders ±1SD (SD= 20.74
mg/L) and span (4-72 mg/L) and we concluded that
distribution was normal (Figure 2).
Average values of magnesium in unstimulated
whole saliva of our patients were aproximately the
same (X=0.46 mmol/L; M=0.43 mmol/L; Mod 
=0.28 mmol/L) with a large dispersion in borders
±1SD (SD=0.20 mmol/L) and span (0.17-0.97
mmol/L) and we concluded that distribution was
normal. Average values of magnesium in stimulated
whole saliva of our patients were aproximately the
same (X=0.41 mmol/L; M=0.39 mmol/L; Mod 
=0.29 mmol/L) with a large dispersion in borders
(SD=0,18 mmol/L) and span (0.15-0.79 mmol/L)
and we concluded that distribution was normal
(Figure 3).
Student t test between values of sIgA in unstim-
ulated and stimulated saliva showed a statistically
significant different values (t=5.88; p<0.001) and
showed a statistically significant decrease of sIgA
in stimulated saliva in relation to unstimulated sali-
va. Additional testing with nonparametric Wilcoxon
test showed statisticaly significantly decreased val-
ues of sIgA in stimulated saliva when compared to
the unstimulated saliva (Z=4.70; p<0.001).
Student t test between lysozyme values in unstim-
ulated and stimulated saliva showed statistically
significant different values (t=2.08; p<0.05) and
showed a statistically significant decrease of lyso-
zyme in stimulated saliva in relation to unstimulated
saliva. Additional testing with nonparametric Wil-
coxon test showed statistically significantly decreased
lysozyme values in stimulated saliva when com-
pared to the unstimulated saliva (Z=1.86; p<0.05).
Student t test between magnesium levels in
unstimulated and stimulated saliva did not show
statistically significantly different values, as well as
testing with Wilcoxon test.
Discussion
The results of our study show that salivary
immunoglobulin A (sIgA) levels decrease together
with salivary stimulation, i.e. levels of sIgA are
decreased in stimulated whole saliva of patients with
burning mouth syndrome and xerostomia when
compared to the sIgA values in unstimulated saliva.
Our results are in concordance with the results of
Rudney et al. (22) who also found negative cor-
relation between sIgA levels and salivary stim-
ulation in healthy individuals. Ryberg et al. (23)
reported decreased levels of sIgA in the stimulated
saliva of patients with asthma when compared to
healthy individuals.
Mandel (24) reported that together with salivary
stimulation levels of sIgA decrease as well in
healthy individuals. The same results were reported
by Gronblad (25), Brandtzaeg (26), Mandel and
Khurana (27) and South et al. (28). Sreebny and
Zhu (29) found elevated sIgA levels in whole
unstimulated saliva of patients with Sjogren syn-
drome. Aguirre et al. (30) did not find any dif-
ferences in sIgA quantity in parotid saliva with
regard to the age of examinees. Syrjanen et al. (31)
found decreased sIgA levels in unstimulated saliva
of patients undergoing radiation therapy. Streckfus
et al. (32) did not find any differences in sIgA
quantity in diabetic patients when compared to a
control group. Gahnberg and Krasse (33) found that
levels of sIgA varied significantly in individuals
over a four month period which could explain huge
differences in sIgA reported in many studies. Narhi
et al. (34) found negative correlation between sIgA
levels and salivary stimulation. 
Our results show that lysozyme levels are decreased
in the stimulated whole saliva of patients with BMS
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and xerostomia and are in concordance with the
findings of Rudney et al. (22) and Narhi (34) in
healthy individuals, although contradictory to the
previous findings of Rudney (22). Jalil et al. (35) did
not report any differences in lysozyme quantitiy in
unstimulated and stimulated saliva of healthy indi-
viduals. Sreebny and Zhu (29) found elevated levels
of lysozyme in the parotid saliva of patients with
Sjogren syndrome. In HIV infected patients, lyso-
zyme levels in unstimulated saliva tend to be ele-
vated when compared to healthy individuals as
reported by Tsang and Samaranayake (36).
Moutsopoulos et al. (37) found elevated levels of
lysozyme in the unstimulated whole saliva of
patients with Sjogren syndrome. Ryberg et al. (23)
found decreased lysozyme levels in the unstim-
ulated saliva of patients with asthma when com-
pared to healthy individuals. Makkonen et al. (38)
reported elevation of lysozyme quantity in patients
undergoing radiation therapy. 
Magnesium levels remain unchanged in unstim-
ulated and stimulated saliva. Our results show that
magnesium secretion is equal for a  short period of
time. Dawes (39) found also unchanged magnesium
levels with regard to salivary stimulation in healthy
individuals. On the other hand Mandel (24) reported
decreased magnesium quantity in stimulated parotid
and submandibular saliva after 2% citric acid stim-
ulation when compared to the levels in unstimulated
saliva. Syrjanen (31) found decreased salivary mag-
nesium levels in patients with galvanism compared
to a control group
Conclusion
On the basis of this study the following can be
concluded:
1. Levels of sIgA in stimulated whole saliva are
decreased when compared to the levels in unstim-
ulated whole saliva of patients with burning
mouth syndrome.
2. Levels of lysozyme are decreased in the stim-
ulated whole saliva of patients with burning
mouth syndrome when compared to the levels in
unstimulated whole saliva. A possible explana-
tion for these results is connected with decreased
functional activity of the salivary glands in
xerostomia and a possible role in the devel-
opment of burning mouth syndrome.
3. Magnesium levels remain unchanged with regard
to stimulation. Salivary glands do not have sig-
nificance in magnesium production and salivary
magnesium does not have an influence on burn-
ing mouth syndrome.
